> Presentations

Please respect the creator's copyright. The articles, images and movies of the presentations are copyrighted by their respective authors. Please do not reproduce this material elsewhere.


Presentation stream 1 – Infection & Metabolism

A1 Marcel Krestakies; Heinrich-Pette Institute Piperidone derivatives for treatment of HIV and HTLV infections and of chronic myeloid leukemia
E3 Martin Raditsch; European Molecular Biology Laboratory, Grenoble Influenza: New target & compounds
A3 Sabina Heim; Hans-Knöll Institute Novel antibiotics for the treatment of methicillin-resistant staphylococcus aureus
U2 Leander Grode; Vakzine Projekt Management GmbH Soluferon® a 2nd generation Interferon-ß with increased bioavailability for the treatment of multiple sclerosis and viral diseases
A5 Dr. Ebensen; Helmholtz Centre for Infection Research Highly potent adjuvants for mucosally administrable vaccines
P3 Dr. Olga Golubnitschaja; University of Bonn Ex vivo-diagnosis and prognosis of early diabetic retinopathy

Presentation stream 2 – Inflammation & Tissue Engineering

I3 Dr. Christian Wunsch; Charité – University Medicine Berlin Nematode derived cystatin inhibits allergic airway Responses and Inflammation
P1 Dr. Christa Müller; University of Bonn and Düsseldorf Phosphorylated A2A receptor agonists as anti-inflammatory agents with improved tolerance
E5 Dr. Beate Niesler; University Clinic Heidelberg New diagnostic biomarkers and therapeutic approaches for irritable bowel syndrome – IBS
M1 Dr. Gehling; Universitätsklinikum Hamburg-Eppendorf Method for carrying out the ex vivo expansion and differentiation of multipotent stem cells
M3 Prof. Wolfram-H. Zimmermann; Universitätsklinikum Hamburg-Eppendorf Engineered Heart Tissue (EHT)
M5 Prof. Wolfram-H. Zimmermann; Universitätsklinikum Hamburg-Eppendorf BioVAD – a biological ventricular assist device

Presentation stream 3 – Oncology & Immune Suppression

A4 Prof. Mühlradt; Helmholtz Centre for Infection MALP-2 – a multitalent for the treatment of cancer, infections, wound healing and autoimmune diseases
D2 Dr. Hedwig Deubzer; Deutsches Krebsforschungszentrum, Heidelberg Drug candidate for treating advanced stage neuroblastoma
D5 Dr. Celina Cziepluch; Deutsches Krebsforschungszentrum, Heidelberg Targeting SGT to eliminate undesired cell populations
U3 Dr. Bernd Eisele; Vakzine Projekt Management GmbH VPM4001 a therapeutic allogeneic vaccine against prostate cancer
U8 Dr. Anita Rudy; Ludwig-Maximilians-Universität, München Small molecule XIAP inhibitor (B64017)
P2 Dr. Anton Schmitz; University of Bonn GEF-inhibitors for the modulation of immune response and insulin signalling

Keynote: Prof. Dr. Günther Wess, Helmholtz Zentrum München “New Cooperation Paradigms between Public Research and Industry”

Presentation stream 4 – Drug Screening & Drug Delivery & Cardiovascular

I1 Marcel Tilmann; Charité – University Medicine, Berlin Method of producing homologous cellular blood components from hematopoietic progenitor cells
I4 Dr. Christian Wunsch; Charité – University Medicine Berlin Method for the identification of Urotensin II converting enzyme inhibitors
F1 Dr. Michaela Weimer; Fraunhofer IGB In vitro human skin test system
F2 Dr. Michaela Weimer; Fraunhofer IGB From model tissues towards functional organs
E4 Dr. Stephan Urban; University Clinic Heidelberg, Germany Peptides as vehicles for specific delivery of compounds to the liver Please contact Prof. Urban if you are interested in receiving his presentation
D3 Prof. Dr. Manfred Wiessler; Deutsches Krebsforschungszentrum, Heidelberg Versatile method to link diagnostics and/or therapeutics to biomolecules